Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$81.22 USD
+0.38 (0.47%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $82.97 +1.75 (2.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 40% (101 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.75 | 1.42 | 9.99 |
Current Quarter Estimate | 1.10 | 1.25 | 61.00 |
Year Ago Quarter Estimate | 1.03 | -4.28 | 54.84 |
Next Quarter Estimate | 0.99 | 1.37 | 63.00 |
Next Year Estimate | 3.86 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 0.50 | 12.30 | 15.67 |
Next Year | -4.22 | 15.10 | 9.31 |
Last 5 Years | 17.00 | 0.10 | 8.10 |
Next 5 Years | 11.10 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 20.15 | 1.64 |
Price/Book (MRQ) | 4.03 | 1.66 |
Price/Cash Flow (MRFY) | 16.02 | 10.44 |
Dividend Yield | 0.50% | 0.00% |
Net Profit Margin (TTM) | 19.97% | NA |
Return on Equity (TTM) | 21.32% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.